Dr. Serota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 NW 14 Street
Suite 851
Miami, FL 33136Phone+1 305-243-8434Fax+1 305-243-5367
Education & Training
- Emory UniversityMSc, Clinical Research, 2017
- Emory University School of MedicineFellowship, Infectious Disease, 2016 - 2019
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2013 - 2016
- University of Miami Leonard M. Miller School of MedicineClass of 2013, MD
- Brown UniversityScB, Neuroscience, 2005 - 2009
Certifications & Licensure
- FL State Medical License 2019 - 2027
- GA State Medical License 2016 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Preventive Medicine Addiction Medicine
- Drug Enforcement AgencyBuprenorphine DATA 2000 waiver
Awards, Honors, & Recognition
- Ruth Fox Scholarship American Society of Addiction Medicine, 2019
- Young Investigator Award Conference on Retroviruses and Opportunistic Infections, 2019
- Howard P. Lewis Award for excellence in medical student teaching Awarded by OHSU School of Medicine Class of 2016, 2016
- Join now to see all
Publications & Presentations
PubMed
- Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs i...Tyler S Bartholomew, Marina Plesons, David P Serota, Elizabeth Alonso, Lisa R Metsch
Addiction Science & Clinical Practice. 2024-03-25 - 5 citationsA confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA.Peyton V Warp, Maia Hauschild, David P Serota, Katrina Ciraldo, Irasema Cruz
Harm Reduction Journal. 2024-03-15 - Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.Carolina Scaramutti, Belén Hervera, Yanexy Rivera, Teresa A Chueng, David W Forrest
Harm Reduction Journal. 2024-02-23
Journal Articles
- Injection Drug Use–Associated Infective EndocarditisDavid Serota, MD, JAMA
Press Mentions
- Addiction Treatment Access Research Wins at American Society of Addiction Medicine ConferenceJune 3rd, 2022
- Pillar of HIV Prevention (PrEP) -- How to ImplementMarch 7th, 2019
- HIV Seroconversion Despite PrEP TherapyNovember 21st, 2018
- Join now to see all
Grant Support
- TL1National Center for the Advancement of Translational SciencePresent
Professional Memberships
- Member
- Member
- Member
- American Society of Addiction MedicineMember
- HIV Medical AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: